Thromb Haemost 2001; 86(04): 1123-1124
DOI: 10.1055/s-0037-1616548
Letters to the Editor
Schattauer GmbH

Persistent Problems with Standardization of Immunoassays for Anti-Cardiolipin Antibodies

Magali Fontaine
1   Department of Pathology, Medical University of South Carolina, Charleston, SC, USA
,
Henry A. Homburger
2   Clinical Immunology Laboratory, USA
,
William L. Nichols
3   Special Coagulation Laboratory, Mayo Clinic, Rochester, MN, USA
› Author Affiliations
Further Information

Publication History

Received 19 April 2001

Accepted after resubmission 30 April 2001

Publication Date:
09 December 2017 (online)

 

 
  • References

  • 1 Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arth Rheum 1999; 42 (Suppl. 07) 1309-11.
  • 2 Harris EN. The second international anticardiolipin workshop / the Kingston anti-phospholipid antibody study (KAPS) group. Am J Clin Pathol 1990; 94: 476-84.
  • 3 Stewart MW, McKay T, Schwind P, Gordon PA. Rapid detection of anticardiolipin antibodies. Am J Hematol 1998; 57 (Suppl. 04) 315-9.
  • 4 Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995; 74: 1185-90.
  • 5 Bacharach JM, Lie JT, Homburger HA. The prevalence of vascular occlusive disease associated with antiphospholipid syndromes. Int Angiol 1992; 11 (Suppl. 01) 51-6.
  • 6 Harris EN, Pierangeli SS, Gharavi AE. Diagnosis of the antiphospholipid syndrome: a proposal for use of laboratory tests. Lupus 1998; 7 (Suppl. 02) 144-8.